BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37178319)

  • 1. Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infections.
    Douglas EJA; Wulandari SW; Lovell SD; Laabei M
    Microb Biotechnol; 2023 Jul; 16(7):1456-1474. PubMed ID: 37178319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review.
    Gopikrishnan M; Haryini S; C GPD
    J Basic Microbiol; 2024 May; 64(5):e2300579. PubMed ID: 38308076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus.
    Assis LM; Nedeljković M; Dessen A
    Drug Resist Updat; 2017 Mar; 31():1-14. PubMed ID: 28867240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
    Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
    Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination approaches to combat multidrug-resistant bacteria.
    Worthington RJ; Melander C
    Trends Biotechnol; 2013 Mar; 31(3):177-84. PubMed ID: 23333434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonconventional Therapeutics against
    Grunenwald CM; Bennett MR; Skaar EP
    Microbiol Spectr; 2018 Nov; 6(6):. PubMed ID: 30547858
    [No Abstract]   [Full Text] [Related]  

  • 9. Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.
    Valdes-Pena MA; Massaro NP; Lin YC; Pierce JG
    Acc Chem Res; 2021 Apr; 54(8):1866-1877. PubMed ID: 33733746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.
    Zhang G; Zhao Y; Paramasivan S; Richter K; Morales S; Wormald PJ; Vreugde S
    Int Forum Allergy Rhinol; 2018 Mar; 8(3):406-414. PubMed ID: 29240296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.
    Eliopoulos GM
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):826-31. PubMed ID: 16315008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review.
    Avedissian SN; Rhodes NJ; Shaffer CL; Tran L; Bradley JS; Le J
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1107-1116. PubMed ID: 33554692
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapeutic Strategies for Combating Staphylococcus aureus Infections.
    Sharma N; Chhillar AK; Dahiya S; Punia A; Choudhary P; Gulia P; Behl A; Dangi M
    Mini Rev Med Chem; 2022; 22(1):26-42. PubMed ID: 33797362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors.
    Kumar G; Kiran Tudu A
    Bioorg Med Chem; 2023 Feb; 80():117187. PubMed ID: 36731248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus.
    Vermote A; Van Calenbergh S
    ACS Infect Dis; 2017 Nov; 3(11):780-796. PubMed ID: 28889735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives.
    Fitzgerald-Hughes D; Devocelle M; Humphreys H
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):399-412. PubMed ID: 22409572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Antimicrobial Photodynamic Therapy of Biofilm-Embedded and Intracellular Staphylococci with a Phage Endolysin's Cell Binding Domain.
    Bispo M; Santos SB; Melo LDR; Azeredo J; van Dijl JM
    Microbiol Spectr; 2022 Feb; 10(1):e0146621. PubMed ID: 35196798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model.
    Kong C; Yehye WA; Abd Rahman N; Tan MW; Nathan S
    BMC Complement Altern Med; 2014 Jan; 14():4. PubMed ID: 24393217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the therapeutic potential of staphylococcal phage formulations: Current challenges and applications in phage therapy.
    Khullar L; Harjai K; Chhibber S
    J Appl Microbiol; 2022 May; 132(5):3515-3532. PubMed ID: 35064991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.